glp 1 regulations GLP-1 Medications: Everything You Need to Know SAHPRA warns the public about
Description
That cardiovascular indication is a clinically and commercially powerful differentiator
doi: 10.1038/s41467-024-54367-y, PMID: [DOI] [PMC free article] [PubMed] [Google Scholar] 50
There is no single correct maintenance dose
2025 Jan;35(1):69-78
Lancet 398, 18111824 (2021)
